BCL10 抗体 (AA 35-51)
Quick Overview for BCL10 抗体 (AA 35-51) (ABIN2617505)
抗原
See all BCL10 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 35-51
-
特异性
- Ubiquitous.
-
交叉反应 (详细)
- No cross reactivity with other proteins.
-
纯化方法
- Immunogen affinity purified
-
免疫原
- A synthetic peptide corresponding to a sequence at the N-terminus of human Bcl10(35-51aa ERHFDHLRAKKILSRED), identical to the related rat and mouse sequences.
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
储存液
- Sodium azide, Thimerosal (Merthiolate)
-
注意事项
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
别名
- BCL10 / BCL-10
-
背景
-
Name/Gene ID: BCL10
Family: Apoptosis
Synonyms: BCL10, Bcl-10, B-cell CLL/lymphoma 10, B-cell lymphoma/leukemia 10, CARMEN, CARD-like apoptotic protein, CCARMEN, C-E10, CIPER, Cellular-E10, HCLAP, Cellular homolog of vCARMEN, CLAP, ME10 -
基因ID
- 8915
-
途径
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
抗原
-